Radiolabeled Compounds in the Development of Cytotoxic Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|24|2923-2934

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.24, 2004-09, pp. : 2923-2934

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Radiolabeled Compounds for Myocardial Perfusion Imaging

By  

Current Pharmaceutical Design, Vol. 18, Iss. 8, 2012-03 ,pp. : 1041-1057

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Radiolabeled Compounds for ADME Studies in Discovery and Exploratory Development

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2991-3008

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Radiolabeled Compounds for Drug Discovery and Development (Executive Editor: Antti Jekunen)]

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : i-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Radiolabeled Compounds for Drug Discovery and Development (Executive Editor: Antti Jekunen)]

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : ii-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Detection of Fungal Infections Using Radiolabeled Antifungal Agents

By  

Current Drug Targets, Vol. 6, Iss. 8, 2005-12 ,pp. : 945-954

Bentham Science Publishers

Access to resources Recommend Favorite